The performance ceiling for non-invasive Brain-Computer Interfaces (BCIs) is rising dramatically, not from better sensors, but from advanced AI. New models can extract high-fidelity signals from noisy data collected outside the skull, potentially making surgical implants like Neuralink unnecessary for sophisticated use cases.

The sci-fi allure of brain implants and embedded chips often overshadows practical alternatives. Ariel Poler argues that most desired functionalities, from interfacing with AI to carrying identification, can be achieved with less invasive external devices like advanced hearables or wearables, questioning the necessity of risky surgical augmentation for healthy individuals.

A new wave of therapies for Stargardt disease is moving beyond simply slowing progression. Approaches like optogenetics aim to restore vision even in advanced patients by creating new light-sensing capabilities in retinal cells, bypassing the photoreceptors already lost to the disease.

Experiments show that long-wavelength red and infrared light can penetrate the human skull, which it passes through more easily than deoxygenated blood in veins. This property is already being used by biomedical engineers to non-invasively monitor mitochondrial function in the brains of newborns who have suffered a stroke.

Challenging Neuralink's implant-based BCI, Merge Labs is creating a new paradigm using molecules, proteins, and ultrasound. This less invasive approach aims for higher bandwidth by interfacing with millions of neurons, fundamentally rethinking how to connect brains to machines.

The primary motivation for biocomputing is not just scientific curiosity; it's a direct response to the massive, unsustainable energy consumption of traditional AI. Living neurons are up to 1,000,000 times more energy-efficient, offering a path to dramatically cheaper and greener AI.

The next frontier for Neuralink is "blindsight," restoring vision by stimulating the brain. The primary design challenge isn't just technical; it's creating a useful visual representation with very few "pixels" of neural stimulation. The problem is akin to designing a legible, life-like image using Atari-level graphics.

While current brain-computer interfaces (BCIs) are for medical patients, the timeline for healthy individuals to augment their brains is rapidly approaching. A child who is five years old today might see the first healthy human augmentations before they graduate high school, signaling a near-term, transformative shift for society.

Many biological processes like hormone regulation and mood are triggered by light hitting non-visual melanopsin cells in the retina. Blind people who still have their eyes can activate these powerful health pathways through light exposure.